Cargando…
A Comparative Study of Replication-Incompetent and -Competent Adenoviral Therapy-Mediated Immune Response in a Murine Glioma Model
Oncolytic virotherapy is a treatment approach with increasing clinical relevance, as indicated by the marked survival benefit seen in animal models and its current exploration in human patients with cancer. The use of an adenovirus vector for this therapeutic modality is common, has significant clin...
Autores principales: | Kim, Julius W., Miska, Jason, Young, Jacob S., Rashidi, Aida, Kane, J. Robert, Panek, Wojciech K., Kanojia, Deepak, Han, Yu, Balyasnikova, Irina V., Lesniak, Maciej S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
American Society of Gene & Cell Therapy
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5443908/ https://www.ncbi.nlm.nih.gov/pubmed/28573184 http://dx.doi.org/10.1016/j.omto.2017.05.001 |
Ejemplares similares
-
Hitting the nail on the head: combining oncolytic adenovirus-mediated virotherapy and immunomodulation for the treatment of glioma
por: Panek, Wojciech K., et al.
Publicado: (2017) -
The use of anti-GITR antibody treatment in a murine model of glioblastoma multiforme
por: Miska, Jason, et al.
Publicado: (2015) -
A novel single-chain antibody redirects adenovirus to IL13Rα2-expressing brain tumors
por: Kim, Julius W., et al.
Publicado: (2015) -
Combination of tucatinib and neural stem cells secreting anti-HER2 antibody prolongs survival of mice with metastatic brain cancer
por: Cordero, Alex, et al.
Publicado: (2021) -
Intranasal Oncolytic Virotherapy with CXCR4-Enhanced Stem Cells Extends Survival in Mouse Model of Glioma
por: Dey, Mahua, et al.
Publicado: (2016)